Cost and effectiveness of omega-3 fatty acid supplementation in Chinese ICU patients receiving parenteral nutrition

ClinicoEconomics and Outcomes Research

Volumn 7, Issue , 2015, Pages 369-375

  Wu, Guo Hao ^a   Gao, Jian ^b   Ji, Chun Yan ^b   Pradelli, Lorenzo ^c   Xi, Qiu Lei ^a   Zhuang, Qiu Lin ^a  

^a Department of General Surgery ^*  (China)

^b FUDAN UNIVERSITY   (China)

^c AdRes Health Economics and Outcomes Research   (Italy)

Author keywords

External validation; ICU patients; Length of hospital stay; Microsimulation; Omega 3 PUFA enriched lipids; Total costs

Indexed keywords

OMEGA 3 FATTY ACID; OMEGAVEN;

ARTICLE; CHINESE; CLINICAL EFFECTIVENESS; COST CONTROL; HEALTH CARE COST; HUMAN; INFECTION RATE; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; PARENTERAL NUTRITION; RELIABILITY; TREATMENT OUTCOME; VALIDITY;

EID: 84936888721     PISSN: None     EISSN: 11786981     Source Type: Journal    
DOI: 10.2147/CEOR.S81277     Document Type: Article

References (23)

1. Russell C, Elia M. Nutrition Screening Week in the UK and Republic of Ireland in 2011. Hospitals, Care Homes and Mental Health Units. Redditch, UK: BAPEN; 2012. Available from: http://www.bapen.org.uk/professionals/publications-and-resources/bapen-reports. Accessed May 14, 2015.
2. Russell C, Elia M. Nutrition Screening Survey in the UK in 2008. Hospitals, Care Homes and Mental Health Units. Redditch, UK: BAPEN; 2009. Available from: http://www.bapen.org.uk/professionals/publications-and-resources/bapen-reports. Accessed May 14, 2015.
3. Schindler K, Pernicka E, Laviano A, et al. How nutritional risk is assessed and managed in European hospitals: a survey of 21,007 patients fndings from the 2007–2008 cross-sectional nutritionDay survey. Clin Nutr. 2010;29(5):552–559.
4. Meijers JM, Schols JM, Van Bokhorst-de van derSchueren MA, Dassen T, Janssen MA, Halfens RJ. Malnutrition prevalence in the Netherlands: results of the annual Dutch national prevalence measurement of care problems. Br J Nutr. 2009;101(3):417–423.
5. Russell C, Elia M. Nutrition Screening Survey and Audit of Adults on Admission to Hospitals, Care Homes and Mental Health Units. Redditch, UK: BAPEN; 2008. Available from: http://www.bapen.org.uk/profession-als/publications-and-resources/bapen-reports. Accessed May 14, 2015.
6. Russell C, Elia M. Nutrition Screening Week in the UK and Republic of Ireland in 2010. Hospitals, Care Homes and Mental Health Units. Redditch, UK: BAPEN; 2011. Available from: http://www.bapen.org.uk/professionals/publications-and-resources/bapen-reports. Accessed May 14, 2015.
7. Liang X, Jiang ZM, Nolan MT, et al. Nutritional risk, malnutrition (undernutrition), overweight, obesity and nutrition support among hospitalized patients in Beijing teaching hospitals. Asia Pac J Clin Nutr. 2009;18(1):54–62.
8. Liang X, Jiang ZM, Nolan MT, Efron DT, Kondrup J. Comparative survey on nutritional risk and nutritional support between Beijing and Baltimore teaching hospitals. Nutrition. 2008;24:969–976.
9. Lim SL, Ong KC, Chan YH, Loke WC, Ferguson M, Daniels L. Malnutrition and its impact on cost of hospitalization, length of stay, readmission and 3-year mortality. Clin Nutr. 2012;31(3):345–350.
10. Sorensen J, Kondrup J, Prokopowicz J, et al. EuroOOPS: an international, multicentre study to implement nutritional risk screening and evaluate clinical outcome. Clin Nutr. 2008;27:340–349.
11. Schneider SM, Veyres P, Pivot X, et al. Malnutrition is an independent factor associated with nosocomial infections. Br J Nutr. 2004;92(1): 105–111.
12. Elia M, Stratton R, Russell C, Green C, Pan F. The Cost of Disease-related Malnutrition in the UK and Economic Considerations for the Use of Oral Nutritional Supplements (ONS) in Adults. Redditch, UK: BAPEN; 2005. Available from: http://www.bapen.org.uk/professionals/publications-and-resources/bapen-reports. Accessed May 14, 2014.
13. Stratton RJ. Malnutrition: another health inequality? Proc Nutr Soc. 2007;66:522–529.
14. Ljungqvist O, de Man F. Under nutrition – a major health problem in Europe. Nutr Hosp. 2009;24(3):368–370.
15. Jie B, Jiang ZM, Nolan MT, et al. Impact of nutritional support on clinical outcome in patients at nutritional risk: a multicenter, prospective cohort study in Baltimore and Beijing teaching hospitals. Nutrition. 2010;26(11):1088–1093.
16. Martin CM, Doig GS, Heyland DK, Morrison T, Sibbald WJ; for the Southwestern Ontario Critical Care Research Network. Multicentre, cluster-randomized clinical trial of algorithms for critical-care enteral and parenteral therapy (ACCEPT). CMAJ. 2004;170(2): 197–204.
17. Pradelli L, Mayer K, Muscaritoli M, Heller AR. n-3 fatty acid-enriched parenteral nutrition regimens in elective surgical and ICU patients: a meta-analysis. Crit Care. 2012;16(5):R184. (A correction for this article has been published in Crit Care. 2012;17:405).
18. Singer P, Berger MM, Van den Berghe G, et al. ESPEN Guidelines on Parenteral Nutrition: intensive care. Clin Nutr. 2009;28:387–400.
19. Brager M, Ljundqvist O, Soeters P, Fearon K, Weimann A, Bozetti F. ESPEN Guidelines on Parenteral Nutrition: surgery. Clin Nutr. 2009;28: 378–386.
20. Gao J, Ji CY, Wu GH. [Use of fsh oil lipid emulsion in patients undergoing major surgery and those with systemic infammatory response syndrome: a cost-effectiveness analysis]. Zhonghua Wei Chang Wai Ke Za Zhi. 2012;15(5):452–456. Chinese.
21. Caro JJ. Pharmacoeconomic analyses using discrete event simulation. Pharmacoeconomics. 2005;23:323–332.
22. Pradelli L, Eandi M, Povero M, et al. Cost-effectiveness of omega-3 fatty acid supplements in parenteral nutrition therapy in hospitals: a discrete event simulation model. Clin Nutr. 2014;33(5):785–792.
23. Progetto MARGHERITA – Rapporto 2009. Gruppo Italiano per la Valutazione degli Interventi in Terapia Intensiva (GIVITI). Sestante Edizioni – Bergamo, 2010. [MARGHERITA Project – 2009 report. Italian Group for the Evaluation of Intensive Therapy Interventions (GIVITI)]. Italian.